Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nexeption
AddedFeb 15, 2024
UpdatedJun 18, 2026
Nexeption

Nexeption

NeXeption, LLC: A biopharmaceutical management firm expert in capital raising, strategic partnerships, and product advancement.

HQ
Malvern, AR, US
Founded
2013
Overview
Compare
Fundraising
Employees

Nexeption, LLC is a biopharmaceutical management company focused on integrating product opportunities, management expertise, and funding to achieve significant partnership milestones. The company specializes in raising capital, operating development-stage companies, and forming strategic alliances to advance products for patient benefit.

Nexeption's management team has a proven track record in the biopharmaceutical industry, successfully securing investments and forging strategic partnerships. Their efforts have significantly impacted the advancement of various biopharmaceutical products, enhancing patient care and treatment options.

Nexeption - Similar Companies

Biotechonomy logo

Biotechonomy

Nexue logo

Nexue

nexue.cloud

Nexo Therapeutics logo

Nexo Therapeutics

nexotx.com

NExTNet logo

NExTNet

nextnetinc.com

Xontogeny logo

Xontogeny

xontogeny.com

Curie.Bio logo

Curie.Bio

curie.bio

NXT Biomedical logo

NXT Biomedical

nxtbiomedical.com

Nexion Biosciences logo

Nexion Biosciences

Bioventure Partners logo

Bioventure Partners

Commerce Health Ventures logo

Commerce Health Ventures

Monon Bioventures logo

Monon Bioventures

Nexgenix logo

Nexgenix

Xoc Pharmaceuticals logo

Xoc Pharmaceuticals

Brace Pharma logo

Brace Pharma

bracepharma.com

Excepgen logo

Excepgen

excepgen.com

Nexeption - Quick Facts

Who are Nexeption's competitors?

Companies similar to Nexeption include Biotechonomy, Nexue, Nexo Therapeutics and NExTNet.

When was Nexeption founded?

Nexeption was founded in 2013.

Where is Nexeption's headquarters located?

Nexeption's headquarters is located in Malvern, AR, US.

When was Nexeption's last funding round?

Nexeption's most recent funding round was for $21.5M (USD) in January 2014.

How much has Nexeption raised to-date?

As of Jan 2, 2014, Nexeption has raised a total of $21.5M (USD).

How many employees does Nexeption have?

Nexeption has 14 employees as of Feb 4, 2024.

Nexeption - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
  • Venture Capital
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
Tags
  • Biotech
  • Consulting
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 18 more industry codes
NAICS
  • 334100Computer and Peripheral Equipment Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 334110Computer and Peripheral Equipment Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 334118Computer Terminal and Other Computer Peripheral Equipment Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 3500Industrial And Commercial Machinery And Computer Equipment
  • 5700Home Furniture, Furnishings, And Equipment Stores
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 3570Computer And Office Equipment
  • 5730Radio, Television, Consumer Electronics, And Music Stores
  • 8730Research, Development, And Testing Services
  • 5734Computer And Computer Software Stores
  • 8731Commercial Physical and Biological Research